Centering Patient Expectations of a Novel Home-Based Oral Drug Treatment among T. b. rhodesiense Human African Trypanosomiasis Patients in Uganda

The recent approval of fexinidazole for human African trypanosomiasis (HAT) caused by T. b. gambiense enables improved patient management that is pivotal to elimination. Effective in both the early and late stages of the disease, it obviates the need for invasive lumbar punctures which guide therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Shona J, Apio, Renah J, Palmer, Jennifer J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157203/
https://www.ncbi.nlm.nih.gov/pubmed/31973101
http://dx.doi.org/10.3390/tropicalmed5010016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157203/
https://www.ncbi.nlm.nih.gov/pubmed/31973101
http://dx.doi.org/10.3390/tropicalmed5010016

Ejemplares similares